These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 22864966)

  • 41. Amisulpride improves obsessive-compulsive symptoms in schizophrenia patients taking atypical antipsychotics: an open-label switch study.
    Kim SW; Shin IS; Kim JM; Yang SJ; Hwang MY; Yoon JS
    J Clin Psychopharmacol; 2008 Jun; 28(3):349-52. PubMed ID: 18480697
    [No Abstract]   [Full Text] [Related]  

  • 42. Short-term sulpiride treatment of children and adolescents with Tourette syndrome or chronic tic disorder.
    Ho CS; Chen HJ; Chiu NC; Shen EY; Lue HC
    J Formos Med Assoc; 2009 Oct; 108(10):788-93. PubMed ID: 19864199
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Usefulness of olanzapine in refractory panic attacks.
    Khaldi S; Kornreich C; Dan B; Pelc I
    J Clin Psychopharmacol; 2003 Feb; 23(1):100-1. PubMed ID: 12544382
    [No Abstract]   [Full Text] [Related]  

  • 44. Positron emission tomography measurement of dopamine D₂ receptor occupancy in the pituitary and cerebral cortex: relation to antipsychotic-induced hyperprolactinemia.
    Arakawa R; Okumura M; Ito H; Takano A; Takahashi H; Takano H; Maeda J; Okubo Y; Suhara T
    J Clin Psychiatry; 2010 Sep; 71(9):1131-7. PubMed ID: 20361897
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Localization of dopamine receptor subtypes occupied by intra-accumbens antagonists that reverse cocaine-induced locomotion.
    Neisewander JL; O'Dell LE; Redmond JC
    Brain Res; 1995 Feb; 671(2):201-12. PubMed ID: 7743209
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Binding of the D3-preferring antipsychotic candidate F17464 to dopamine D3 and D2 receptors: a PET study in healthy subjects with [
    Slifstein M; Abi-Dargham A; Girgis RR; Suckow RF; Cooper TB; Divgi CR; Sokoloff P; Leriche L; Carberry P; Oya S; Joseph SK; Guiraud M; Montagne A; Brunner V; Gaudoux F; Tonner F
    Psychopharmacology (Berl); 2020 Feb; 237(2):519-527. PubMed ID: 31773210
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs.
    Farde L; Wiesel FA; Halldin C; Sedvall G
    Arch Gen Psychiatry; 1988 Jan; 45(1):71-6. PubMed ID: 2892477
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Sulpiride as initial treatment in tinnitus retraining therapy].
    López González MA; Muratori León ML; Moreno Vaquera J
    Acta Otorrinolaringol Esp; 2003 Apr; 54(4):237-41. PubMed ID: 12825239
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Effects of a single injection of barnetil in emergency psychiatry. Apropos of 100 cases].
    Caroli F; Giuliano G
    Ann Med Psychol (Paris); 1979; 137(3-4):222-30. PubMed ID: 40510
    [No Abstract]   [Full Text] [Related]  

  • 50. Dopamine D2 and D4 receptor ligands: relation to antipsychotic action.
    Wilson JM; Sanyal S; Van Tol HH
    Eur J Pharmacol; 1998 Jun; 351(3):273-86. PubMed ID: 9721018
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Amphetamine-induced locomotor stereotypy in rats is reduced by a D1 but not a D2 antagonist.
    Fritts ME; Mueller K; Morris L
    Pharmacol Biochem Behav; 1997 Dec; 58(4):1015-9. PubMed ID: 9408208
    [TBL] [Abstract][Full Text] [Related]  

  • 52. How do we choose between atypical antipsychotics? The advantages of amisulpride.
    Mortimer AM
    Int J Neuropsychopharmacol; 2004 Mar; 7 Suppl 1():S21-5. PubMed ID: 14972081
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [In vitro pharmacology of antipsychotics at human dopamine D2 and D3 receptors].
    Tadori Y; Kobayashi H
    Nihon Yakurigaku Zasshi; 2014 Dec; 144(6):265-71. PubMed ID: 25492361
    [No Abstract]   [Full Text] [Related]  

  • 54. I.V. APD421 (amisulpride) prevents postoperative nausea and vomiting: a randomized, double-blind, placebo-controlled, multicentre trial.
    Kranke P; Eberhart L; Motsch J; Chassard D; Wallenborn J; Diemunsch P; Liu N; Keh D; Bouaziz H; Bergis M; Fox G; Gan TJ
    Br J Anaesth; 2013 Dec; 111(6):938-45. PubMed ID: 23872464
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clozapine treatment of schizophrenia.
    Pickar D; Hsiao JK
    JAMA; 1995 Sep; 274(12):981-3. PubMed ID: 7674530
    [No Abstract]   [Full Text] [Related]  

  • 56. Acutely administered antipsychotic drugs are highly selective for dopamine D2 over D3 receptors.
    McCormick PN; Wilson VS; Wilson AA; Remington GJ
    Pharmacol Res; 2013 Apr; 70(1):66-71. PubMed ID: 23327779
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Amisulpride monotherapy may be a choice of maintenance treatment for patients with both bipolar I disorder and metabolic syndrome.
    Hong CC; Chen CK; Yeh TC; Chu CS; Chen TY
    Aust N Z J Psychiatry; 2015 Aug; 49(8):757-8. PubMed ID: 25788497
    [No Abstract]   [Full Text] [Related]  

  • 58. Prolactinemia is uncoupled from central D2/D3 dopamine receptor occupancy in amisulpride treated patients.
    Bressan RA; Erlandsson K; Spencer EP; Ell PJ; Pilowsky LS
    Psychopharmacology (Berl); 2004 Sep; 175(3):367-73. PubMed ID: 14997280
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Olanzapine and panic attacks.
    Etxebeste M; Aragüés E; Malo P; Pacheco L
    Am J Psychiatry; 2000 Apr; 157(4):659-60. PubMed ID: 10739446
    [No Abstract]   [Full Text] [Related]  

  • 60. The D2 receptor: love it and leave it.
    Pickar D
    Mol Psychiatry; 1998 Mar; 3(2):101-2. PubMed ID: 9577830
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.